NIHON CHOUZAI Co.,Ltd.
NIHON CHOUZAI Co.,Ltd. (3341.T) Financial Performance & Income Statement Overview
Analyze NIHON CHOUZAI Co.,Ltd. (3341.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
NIHON CHOUZAI Co.,Ltd. (3341.T) Income Statement & Financial Overview
Review NIHON CHOUZAI Co.,Ltd. 3341.T income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $90.71B | $94.22B | $89.14B | $86.43B |
| Cost of Revenue | $76.35B | $78.35B | $75.28B | $73.16B |
| Gross Profit | $14.36B | $15.87B | $13.86B | $13.27B |
| Gross Profit Ratio | $0.16 | $0.17 | $0.16 | $0.15 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $11.85B | $12.73B | $13.20B | $13.67B |
| Operating Expenses | $11.85B | $12.56B | $13.20B | $13.07B |
| Total Costs & Expenses | $88.21B | $90.91B | $88.48B | $86.24B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $127.00M | $121.00M | $115.00M | $97.00M |
| Depreciation & Amortization | $2.78B | $2.23B | $2.32B | $2.27B |
| EBITDA | $3.67B | $5.41B | $3.08B | $2.44B |
| EBITDA Ratio | $0.04 | $0.06 | $0.03 | $0.03 |
| Operating Income | $2.51B | $3.31B | $661.00M | -$399.00M |
| Operating Income Ratio | $0.03 | $0.04 | $0.007 | -$0.005 |
| Other Income/Expenses (Net) | -$1.74B | -$1.99B | $5.00M | $495.00M |
| Income Before Tax | $764.00M | $1.32B | $666.00M | $98.00M |
| Income Before Tax Ratio | $0.008 | $0.01 | $0.007 | $0.001 |
| Income Tax Expense | -$10.00M | $665.00M | $568.00M | $238.00M |
| Net Income | $774.00M | $660.00M | $97.00M | -$140.00M |
| Net Income Ratio | $0.009 | $0.007 | $0.001 | -$0.002 |
| EPS | $25.90 | $22.09 | $3.24 | -$4.68 |
| Diluted EPS | $25.90 | $22.09 | $3.24 | -$4.68 |
| Weighted Avg Shares Outstanding | $29.89M | $29.88M | $29.92M | $29.92M |
| Weighted Avg Shares Outstanding (Diluted) | $29.89M | $29.88M | $29.92M | $29.92M |
Over the last four quarters, NIHON CHOUZAI Co.,Ltd. achieved steady financial progress, growing revenue from $86.43B in Q1 2024 to $90.71B in Q4 2024. Gross profit stayed firm with margins at 16% in Q4 2024 versus 15% in Q1 2024. Operating income totaled $2.51B in Q4 2024, maintaining a 3% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $3.67B. Net income rose to $774.00M, with EPS at $25.90. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan